private financing
Gritstone Bio Raises $55M in PIPE Financing
Frazier Life Sciences Public Fund, Redmile Group, and Gilead Sciences contributed funds, which will be used to advance the use of its EDGE platform in vaccine development.
Nuvectis Closes $15M Series A Funding Round; Licenses HSF1 Inhibitor From CRT Pioneer Fund
The company will begin a Phase I trial of NXP800 this year in advanced solid tumors and focus on exploiting synthetic lethality mechanisms.
InterVenn Biosciences Closes $201M Series C Round
The company said it planned to use the funds for the development of a liquid biopsy assay for predicting patient response to immune checkpoint inhibitors.
Frontier Medicines Nets $88.5M in Series B Funding
The company will use the funding to advance its lead candidate targeting KRAS G12C, which is still in the discovery phase.
XCures Raises $12.7M in Series A Funding
The funding will support development and adoption of its AI-powered clinical decision-making platform.
May 11, 2021
Nuvalent Raises $135M in Series B Funding
Mar 16, 2021
Acepodia Raises $47M in Series B Financing
Feb 17, 2021
Cancer Detection Firm Micronoma Raises $3.5M
Jan 19, 2021
OncoHost Raises $8 Million in Series B Funding Round
Jan 13, 2021
OncoLens Raises $7.25 Million in Series A Funding
Dec 28, 2020
Gritstone Raises $125M in Private Financings
Aug 20, 2020